2020年11月四川大学华西医院曹丹教授在《Tumori Journal》上发表了一篇case report: Efficacy of chemotherapy combined with toripalimab inPD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma:.....
近日,湖南省肿瘤医院杨农教授和张永昌教授团队在Cancer Immunology, Immunotherapy(IF 5.442)杂志上发表了一篇PD-1抑制剂联合安罗替尼在晚期肺癌患者应用的真实世界研究《Anlotinib combined with PD-1 blockade for thetreatment
2021年11月2日美国学术出版学会(Society for Scholarly Publishing)的官方媒体《学术厨房》(Scholarly Kitchen),即SK的编辑,同时兼任《美国心脏学会会刊-亚洲版》(Asia at American College of Cardiology)编辑部主任的.....
今天,我们继续解读柳叶刀2021年8月发表的关于高血压初始治疗策略对比的论文,论文标题:Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines vers.....
本文选自中国工程院院刊《Engineering》2021年第7期作者:赖圣杰,Nick W. Ruktanonchai,Alessandra Carioli,Corrine W. Ruktanonchai,Jessica R. Floyd,Olivia Prosper,张弛,杜向军,杨维中,Andrew J. Tatem来源:Assessing the .....
[1]Jonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, et al. Durvalumab,with or without tremelimumab,plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cel.....